Back to News
Activism

Lawyers Debate Icahn-Oxy Feud

|
Published: December 3rd, 2019
Sidley's Kai Liekefett and Schulte's Ele Klein diverge in their opinions about Carl Icahn’s unyielding agitation at Occidental Petroleum.

Two of the country’s top attorneys involved in launching and defending shareholder activist campaigns on Wednesday, Nov. 20, diverged in their opinions about Carl Icahn’s unyielding agitation at Occidental Petroleum Corp. (OXY).

Icahn has taken issue with Occidental Petroleum’s $38 billion recently closed acquisition of Anadarko Petroleum Corp. and two related deals, arguing they were hugely destructive for shareholder value.

Sidley Austin LLP’s Kai Liekefett, who co-chair’s the firm’s activist practice, defended the company, suggesting Icahn should back off and give the friendly deal a chance.

Meanwhile, Ele Klein, co-chair of the global shareholder activism group at Schulte Roth & Zabel LLP and whose practice supports activists in their campaigns, took issue with the deal’s funding and its impact on voting rights for OXY shareholders. He refrained from commenting on whether the price was too high. He suggested, however, that the company was trying to avoid a shareholder vote by raising the cash component to finance the deal.

“How do you know what most of the investors think?” Klein said. “Didn’t the company make sure that they weren’t going to have to ask them those questions about how they restructured the deal and make sure they didn’t know what the investors wanted?”

—Ronald Orol contributed to this report

Editor’s note: The original version of this article was published earlier on The Deal’s premium subscription website. For access, log in to TheDeal.com or use the form below to request a free trial.

This Content is Only for The Deal Subscribers

The Deal provides actionable, intraday coverage of mergers, acquisitions and all other changes in corporate control to institutional investors, private equity, hedge funds and the firms that serve them.

If you’re already a subscriber, log in to view this article here.

More From Activism

Activism

Activist Investing Today: Privet’s Rosenzweig on Synalloy, Covid-19

By Ronald Orol
|
Published: March 30th, 2020
The partner at the event-driven and value-oriented insurgent fund explains why he is plodding ahead with a change-of-control director contest at a metals and specialty company even though he is 'cognizant' of the coronavirus' effects on the world.
Activism

Activist Investing Today: Coast's Rasteh on FirstGroup, Covid-19

By Ronald Orol
|
Published: March 23rd, 2020
The founder of the New York-based activist fund explains why he's sticking with his investment and campaign at transport and school bus company FirstGroup — one of the fund's largest positions — even as its share price gets battered.
Activism

Activist Investing Today: V&E's Elbaum on Covid-19 vs. 2008

By Ronald Orol
|
Published: March 13th, 2020
The co-head of the shareholder activism practice at Vinson & Elkins explains what the 2008 financial crisis can teach us about how activists might react and perform during the coronavirus outbreak.